参考文献/References:
[1]中华医学会肾脏病学分会专家组.糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志,2021,37(3):225-304.[2]Ruiz OM,Rodrigues DR,Lavoz C,et al.Special Issue "Diabetic Nephropathy: Diagnosis,Prevention and Treatment"[J].J Clin Med,2020,9(3):813.[3]Hu R,Quan S,Wang Y,et al.Spectrum of biopsy proven renal diseases in Central China: a10-year retrospective study based on 34,630 cases[J].Sci Rep,2020,10(1):10994.[4]Yang C,Wang H,Zhao X,et al.CKD in China:Evolving Spectrum and Public Health Implications[J].Am J Kidney Dis,2020,76(2):258-264.[5]翟英,李向东,李毅,等.高通量透析对糖尿病肾脏疾病患者糖基化终产物及微炎症的影响[J].临床肾脏病杂志,2018,18(7):409-412.[6]Ho JE,Liu C,Lyass A,et al.Galectin-3,a marker of cardiac fibrosis,predicts incident heart failure in the community[J].J Am Coll Cardiol,2012,60(14):1249-1256.[7]Alicic RZ,Rooney MT,Tuttle KR.Diabetic Kidney Disease:Challenges,Progress,and Possibilities[J].Clin J Am Soc Nephrol,2017,12(12):2032-2045.[8]Heilig CW,Deb DK,Abdul A,et al.GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy[J].Am J Nephrol,2013,38(1):39-49.[9]Samsu N.Diabetic Nephropathy: Challenges in Pathogenesis,Diagnosis,and Treatment[J].Biomed Res Int,2021,2021:1497449.[10]Kim KS,Park SW,Cho YW,et al.Higher Prevalence and Progression Rate of ChronicKidney Disease in Elderly Patients with Type 2 Diabetes Mellitus[J].Diabetes Metab J,2018,42(3):224-232.[11]Thomas MC,Cooper ME,Zimmet P.Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease[J].Nat Rev Nephrol,2016,12(2):73-81.[12]Perrone A,Giovino A,Benny J,et al.Advanced Glycation End Products (AGEs): Biochemistry,Signaling,Analytical Methods,and Epigenetic Effects[J].Oxid Med Cell Longev,2020,2020:3818196.[13]Snelson M,Coughlan MT.Dietary Advanced Glycation End Products: Digestion,Metabolismand Modulation of Gut Microbial Ecology[J].Nutrients,2019,11(2):215.[14]李兰,李建薇.糖尿病肾病患者糖脂代谢状况与肾功能、炎症反应的相关性[J].海南医学院学报,2017,23(10):1341-1343,1347.[15]Kumar PA,Chitra PS,Reddy GB.Advanced glycation end products mediated cellular andmolecular events in the pathology of diabetic nephropathy[J].Biomol Concepts,2016,7(5-6):293-309.[16]Zhang P,Sun Y,Peng R,et al.Long Non-Coding RNA Rpph1 Promotes Inflammation and Proliferation of Mesangial Cells in Diabetic Nephropathy via an Interaction with Gal-3[J].Cell Death Dis,2019,10:526.[17]Johannes L,Jacob R,Leffler H.Galectins at a glance[J].J Cell Sci,2018,131(9):jcs208884.[18]Newlaczyl AU,Yu LG.Galectin-3--a jack-of-all-trades in cancer[J].Cancer Lett,2011,313(2):123-128.[19]Boutin L,Dépret F,Gayat E,et al.Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target[J].Int J Mol Sci,2022,23(6):3124.[20]Sciacchitano S,Lavra L,Morgante A,et al.Galectin-3: One Molecule for an Alphabet of Diseases,from A to Z[J].Int J Mol Sci,2018,19(2):379.[21]Ji F,Zhang S,Jiang X,et al.Diagnostic and prognostic value of galectin-3,serum creatinine,and cystatin C in chronic kidney diseases[J].J Clin Lab Anal,2017,31(5):e22074.[22]O’Seaghdha CM,Hwang SJ,Ho JE,et al.Elevated galectin-3 precedes the development of CKD[J].J Am Soc Nephrol,2013,24(9):1470-1477.[23]Iacoviello M,Aspromonte N,Leone M,et al.Galectin-3 Serum Levels Are Independently Associated With Microalbuminuria in Chronic Heart Failure Outpatients[J].Res Cardiovasc Med,2015,5(1):e28952.[24]Yilmaz H,Inan O,Darcin T,et al.Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever[J].Clin Exp Nephrol,2015,19(3):436-442.[25]Hodeib H,Hagras MM,Abdelhai D,et al.Galectin-3 as a prognostic biomarker for diabetic nephropathy[J].Diabetes Metab Syndr Obes,2019,12:325-331.[26]Hussain S,Habib A,Hussain MS,et al.Potential biomarkers for early detection of diabetic kidney disease[J].Diabetes Res Clin Pract,2020,161:108082.[27]Tan KCB,Cheung CL,Lee ACH,et al.Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus[J].Diabetologia,2018,61(5):1212-1219.[28]Drechsler C,Delgado G,Wanner C,et al.Galectin-3,Renal Function,and Clinical Outcomes: Results from the LURIC and 4D Studies[J].J Am Soc Nephrol,2015,26(9):2213-2221.[29]Ozkan G,Ulusoy S,Mentese A,et al.Can be galectin-3 a novel marker in determining mortality in hemodialysis patients?[J].Clin Biochem,2015,48(12):768-773.[30]Hogas S,Schiller A,Voroneanu L,et al.Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients[J].Angiology,2016,67(9):854-859.[31]Yücel N,?覶ak?覦r Madenci ?魻,B?觟lük A,et al.Is galectin-3 associated with urinary albumin excretion in type 2 diabetes?[J].Endokrynol Pol,2016,67(6):580-584.[32]Okamura DM,Pasichnyk K,Lopez-Guisa JM,et al.Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis[J].Am J Physiol Renal Physiol,2011,300(1):F245-F253.[33]Luís C,Costa R,Rodrigues I,et al.Xanthohumol and 8-prenylnaringenin reduce type 2 diabetes-associated oxidative stress by downregulating galectin-3[J].Porto Biomed J,2018,4(1):e23.
相似文献/References:
[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(03):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Journal of Medical Information,2018,31(03):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(03):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Journal of Medical Information,2018,31(03):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者
血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with
Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(03):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Journal of Medical Information,2018,31(03):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Journal of Medical Information,2018,31(03):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[8]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Journal of Medical Information,2019,32(03):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[9]张国艳,张佳田,隋洪玉.糖尿病肾病大鼠动物模型建立及INF-α干预机制研究[J].医学信息,2019,32(05):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
ZHANG Guo-yan,ZHANG Jia-tian,SUI Hong-yu.Establishment of Animal Model of Diabetic Nephropathy Rats and Study of INF-α Intervention Mechanism[J].Journal of Medical Information,2019,32(03):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
[10]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Journal of Medical Information,2019,32(03):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]